By Funded Work Editorial Desk · AI-assisted summary · sources linked below when available
Consint.AI Lands $2.65M for AI-Powered Healthcare Fraud Platform
The company announced the $2.65 million funding on August 6, 2026, without disclosing the round type or lead investors.
Consint.AI offers an AI-powered platform designed to help enterprises detect and manage healthcare fraud. The company disclosed a $2,650,602.00 funding round on August 6, 2026, but did not specify the round type—whether seed, Series A, or otherwise—or name any investors. The announcement provided no details on how the capital will be used, leaving the company’s immediate growth plans unclear. Healthcare fraud remains a costly challenge for insurers and providers, with the National Health Care Anti-Fraud Association estimating tens of billions in annual losses in the U.S. alone. AI-driven tools that can sift through claims data to flag suspicious patterns are in growing demand, placing Consint.AI in a competitive but expanding niche. Without further disclosures, it’s uncertain whether this funding will accelerate product development, fuel customer acquisition, or expand the team. The company’s website and public profiles offered no additional commentary at the time of the announcement.
Founders
- Ashish ChaturvediFounder & CEO
- Preeti ChaturvediCOO
- Swadeep SinghCo-Founder
Press
About the Company
Offers an AI-powered healthcare fraud and management platform to enterprises
Consint.ai delivers AI-powered fraud detection, risk assessment, and clinical intelligence solutions for insurance, healthcare, and financial services.